Lynn brings significant sales and marketing experience, including as president and a founding partner of a startup in one-to-one marketing and as a senior vice president at Digitas, managing interactive marketing relationships and strategy development across a range of industries. Lynn spent a decade at the Boston Consulting Group as a member of the Health Care practice focusing on payors and hospitals. She had previously focused on the securities industry and how to use information for strategic advantage. Her work was detailed in her article, “Stay Small or Get Huge: Lessons from the Securities Industry,” published in the Harvard Business Review. She received her M.B.A from Harvard Business School, awarded with distinction and her B.A. from Radcliffe College, with magna cum laude honors.

Dr. Segal did his undergraduate work at Harvard and his MD and PhD at Columbia, where his thesis project outlined rules for the types of chemical synapses that will form in a nervous system. After his residency in pediatric neurology at Columbia, he moved to Harvard Medical School, where he joined the faculty and developed the microisland system for studying neural networks with as few as one or two brain neurons. Using this system, he developed a reductionist model of epilepsy, work that won him national and international young investigator awards, and set the stage for later work on the molecular mechanism of attention deficit disorder. In the 1980s he started teaching at Harvard about the relationship between computer and biological neural networks, as well as publishing about the relationship between artificial intelligence and biological neural networks.  He patterned the SimulConsult software after the way that experienced clinicians actually think about diagnosis. He is on the Professional Development Committee of the Child Neurology Society and has been on the Scientific Program Committee of the American Medical Informatics Association. Click here for a list of publications.

Rick has been building early-stage companies and developing practical, break-through strategies for more than twenty-five years. He has been CEO or COO of eleven companies; most recently Thermalin Diabetes, LLC (CEO, biotech) and HeartLander Surgical, Inc. (CEO, medical device). Rick has also led companies in consumer products manufacturing, knowledge management, new media, entertainment industry technology, manufacturing software, healthcare information and services, healthcare market research, diagnostic reference laboratory services, and cancer immunotherapeutics. He has raised or helped raise more than $35M in private and non-dilutive capital. As Managing Director of his consulting firm, Venzyme Catalyst, LLC, he has helped launch and finance life science organizations around important new technologies in complex markets. Rick received a JD-MBA from Harvard Law and Business Schools in 1984 and is a graduate of Harvard College.

Mark Zbikowski is the CTO at SimulConsult. He is a former Microsoft Architect. He started working at Microsoft only a few years after its inception, leading efforts in MS-DOS, OS/2, Cairo and Windows NT. In 2006, he was honored for 25 years of service with Microsoft, the first employee to reach this milestone other than Bill Gates and Steve Ballmer. Mark retired from Microsoft in June 2006, has served as the CTO at startups and is currently a technical adviser to several companies. He was the designer of the DOS executable file format, used in MS-DOS executable files, and his initials are the first 2 bytes of those files.

David is a retired Senior Partner at The Boston Consulting Group. He founded BCG’s health care practice and has led BCG’s Boston office, among many other roles for the firm. His work has focused on strategies for integrating health care, and especially on the role of health care technology in driving this. He has been deeply associated with the development of disease management and wellness and has published several articles on those topics. David received a JD from Harvard Law School, an MBA from Harvard Business School and an MA from the University of St Andrews.

Rick has been building early-stage companies and developing practical, break-through strategies for more than twenty-five years. He has been CEO or COO of eleven companies; most recently Thermalin Diabetes, LLC (CEO, biotech) and HeartLander Surgical, Inc. (CEO, medical device). Rick has also led companies in consumer products manufacturing, knowledge management, new media, entertainment industry technology, manufacturing software, healthcare information and services, healthcare market research, diagnostic reference laboratory services, and cancer immunotherapeutics. He has raised or helped raise more than $35M in private and non-dilutive capital. As Managing Director of his consulting firm, Venzyme Catalyst, LLC, he has helped launch and finance life science organizations around important new technologies in complex markets. Rick received a JD-MBA from Harvard Law and Business Schools in 1984 and is a graduate of Harvard College.

Lynn brings significant sales and marketing experience, including as president and a founding partner of a startup in one-to-one marketing and as a senior vice president at Digitas, managing interactive marketing relationships and strategy development across a range of industries. Lynn spent a decade at the Boston Consulting Group as a member of the Health Care practice focusing on payors and hospitals. She had previously focused on the securities industry and how to use information for strategic advantage. Her work was detailed in her article, “Stay Small or Get Huge: Lessons from the Securities Industry,” published in the Harvard Business Review. She received her M.B.A from Harvard Business School, awarded with distinction and her B.A. from Radcliffe College, with magna cum laude honors.

Dr. Segal did his undergraduate work at Harvard and his MD and PhD at Columbia, where his thesis project outlined rules for the types of chemical synapses that will form in a nervous system. After his residency in pediatric neurology at Columbia, he moved to Harvard Medical School, where he joined the faculty and developed the microisland system for studying small numbers of brain neurons in culture. Using this system, he developed a simplified model of epilepsy, work that won him national and international young investigator awards, and set the stage for later work on the molecular mechanism of attention deficit disorder. Dr. Segal has a long history of interest in artificial intelligence and neural networks, and patterned the SimulConsult software after the way that experienced clinicians actually think about diagnosis. He is on the Electronic Communication Committee of the Child Neurology Society is one of the medical advisers of the Periodic Paralysis Association, and has been on the Scientific Program Committee of the American Medical Informatics Association. Click here for a list of publications.

Former President & CEO of Atrius Health with over 6,800 clinicians.  Dr. Strongwater is an adult Rheumatologist. Prior to joining Atrius, Dr. Strongwater was the Chief Transformation Officer at Geisinger Health System. He previously had been the CEO of Stony Brook University Hospital. Dr. Strongwater sits on the Mass Digital Health Council and is a board member of Atalan. He received a BS from the University of Rochester and his MD from the Upstate Medical School.